AChE/BChE-IN-43
BChE-IN-54 is a dual AChE/BChE inhibitor (Electrophorus electricus AChE (Ki = 29.05 nM) and equine serum BChE (Ki = 28.68 nM)). BChE-IN-54 can be used in the research of Alzheimer's disease.
For research use only. We do not sell to patients.
- Formula: C31H27F3N4O4
- Molecular Weight:576.57
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
electric eel AChE 29.05 nM (Ki) |
equine serum BChE 28.68 nM (Ki) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| SH-SY5Y | IC50 |
41.53 μM
|
Cytotoxicity against human neuroblastoma SH-SY5Y cells assessed as reduction in cell viability incubated for 24 hrs by crystal violet staining method.
Cytotoxicity against human neuroblastoma SH-SY5Y cells assessed as reduction in cell viability incubated for 24 hrs by crystal violet staining method.
|
42585890 |
In Vitro
BChE-IN-54 (Compound 6) (3.125-200 μM; 24 h) exhibits low cytotoxicity against SH-SY5Y neuronal cells with an IC50 of 41.53 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 576.57
-
Formula C31H27F3N4O4
-
SMILES
COC1=CC(/C=N/NC(C2=CC=C(C=C2)OC3=NC=CC=C3C(F)(F)F)=O)=CC(CN4CC5=C(C=CC=C5)CC4)=C1O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Alzheimer’s Disease Modeling
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a progressive decline in cognitive functions and loss of specific types of neurons and synapses. Alzheimer's symptoms can be simulated in mice by injecting drugs (such as Aβ) or genetically modified.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)